These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4846488)

  • 41. Alloantibody-induced cytotoxicity of macrophages.
    Ptak W; Hanczakowska M
    J Immunol; 1975 Sep; 115(3):796-9. PubMed ID: 1151077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibody-mediated suppression of tumor growth. III. Molecular assay of murine IgG1 alloantibody required to cause tumor suppression in vivo.
    Johnson RJ; Pasternack GR; Drysdale BE; Shin HS
    J Immunol; 1977 Feb; 118(2):498-504. PubMed ID: 839068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth.
    Lamon EW; Powell TJ; Walia AS; Lidin BI; Srinivas RV; Baskin JG; Kearney JF
    J Natl Cancer Inst; 1987 Mar; 78(3):547-56. PubMed ID: 3469466
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Facilitation of tumor growth by syngeneic normal cells mixed with tumor cells in vitro.
    Deckers PJ; Ramming KP; Pilch YH
    Cancer; 1971 Apr; 27(4):897-901. PubMed ID: 5574078
    [No Abstract]   [Full Text] [Related]  

  • 45. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 46. Lymphocytic IgM antibody in highly sensitized (greater than 50% PRA) autologous negative renal allograft candidates.
    Shroyer TW; Diethelm AG; Deierhoi MH; Barber WH; Barger BO
    Transplant Proc; 1989 Feb; 21(1 Pt 1):739-41. PubMed ID: 2650250
    [No Abstract]   [Full Text] [Related]  

  • 47. Ribonucleic acid-mediated inhibition and enhancement of tumor growth in mice.
    Ramming KP; Pilch YH
    Surg Forum; 1969; 20():106-9. PubMed ID: 5383020
    [No Abstract]   [Full Text] [Related]  

  • 48. Immunologicc activity of the aged.
    Makinodan T; Perkins EH; Chen MG
    Adv Gerontol Res; 1971; 3():171-98. PubMed ID: 4398644
    [No Abstract]   [Full Text] [Related]  

  • 49. Production and characterization of monoclonal antibodies to bovine immunoglobulin G2.
    Srikumaran S; Guidry AJ; Goldsby RA
    Am J Vet Res; 1982 Jan; 43(1):21-5. PubMed ID: 7091814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of tumor size on concomitant tumor immunity.
    Deckers PJ; Davis RC; Parker GA; Mannick JA
    Cancer Res; 1973 Jan; 33(1):33-9. PubMed ID: 4682321
    [No Abstract]   [Full Text] [Related]  

  • 51. Crossmatching by complement-dependent lymphocytotoxicity.
    Fidler SJ
    Methods Mol Biol; 2012; 882():359-77. PubMed ID: 22665245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Monoclonal production of both IgM and IgG1 antihapten antibody.
    Press JL; Klinman NR
    J Exp Med; 1973 Jul; 138(1):300-5. PubMed ID: 4736831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.
    Brunner KT; Mauel J; Cerottini JC; Chapuis B
    Immunology; 1968 Feb; 14(2):181-96. PubMed ID: 4966657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of IgG and IgM alloantibodies in the enhancement of mouse skin allografts and the relation with their opsonizing capacity in vivo.
    Lems SP; Tamboer WP; Capel PJ; Koene RA
    J Immunol; 1981 Aug; 127(2):665-9. PubMed ID: 7019328
    [No Abstract]   [Full Text] [Related]  

  • 55. IgM antibodies in renal transplantation.
    McCalmon RT; Tardif GN; Sheehan MA; Fitting K; Kortz W; Kam I
    Clin Transplant; 1997 Dec; 11(6):558-64. PubMed ID: 9408684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of in vivo adsorption of immune serum to donor spleen cells on allograft rejection in X-irradiated mice.
    Cruse JM; Dulaney AD
    Z Immunitatsforsch Allerg Klin Immunol; 1966 May; 130(4):329-36. PubMed ID: 4231165
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunologic enhancement of allogeneic tumor growth with soluble histocompatibility-2 antigens.
    Law LW; Appella E; Wright PW; Strober S
    Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3078-82. PubMed ID: 4108871
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperacute rejection and enhancement of mouse skin grafts by antibodies with a distinct specificity.
    Jansen JL; Koene RA; Kamp GJ; Hagemann JF; Wijdeveld PG
    J Immunol; 1975 Aug; 115(2):392-4. PubMed ID: 1097512
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
    Miller GA; Feldman JD
    J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A preparation of Fc fragment of normal mouse IgG1 for production of rabbit anti mouse IgG1 serum.
    Harris TN; Harris S; Henri EM
    J Immunol Methods; 1975 Sep; 8(3):203-12. PubMed ID: 810516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.